Loading...

VENUSREM Venus Remedies Ltd Legal Disputes Announcement

Vns

VNSR

Venus Remedies Ltd

(VENUSREM)

2024 Announcement

Show Summary

Show Summary

Financial Results Published

Management Changes

GMP Certification Renewed

Compliance Report

Email Address Change

FDA Designation Granted

SEBI Compliance Confirmation

Exclusive Rights Secured

Market Authorization Granted

Financial Results Published

Liability Write-Off

SEBI Compliance Confirmation

Market Expansion

SOP Fine Payment

Marketing Authorization Sec...

Expansion in Hungary

GMP Approval Achieved

Financial Results Published

Regulatory Compliance

Director Retirements

Management Changes

Annual General Meeting

Book Closure Notice

AGM Notice Issued

Financial Results

Management Change

Tax Case Resolution

Compliance Certificate Subm...

Global Fight Against Cancer

UNICEF Award Achievement

Financial Results Publication

Compliance Report Submission

Confirmation Certificate Su...

Compliance Certificate Subm...

Compliance Certificate

PLI Incentive Awarded

Award of Incentive

Approval from UNICEF

Marketing Approval

VENUS REMEDIES LTD.

Newspaper Publication

Marketing Authorizations

GMP Certification

Marketing Authorizations Se...

Achievements in marketing a...

Venus Remedies Ltd. Transfo...

New Marketing Authorizations

Fined for omission of finan...

Market Authorizations Granted

Marketing Authorizations in...

Financial Results Publication

Export House Certificate

FICCI Healthcare Award 2023

market authorization

REO Certification

ASEAN expansion

Global Expansion

Compliance Confirmation Cer...

Award Announcement

Oncology Portfolio Expansion

DSIR Registration for Custo...

Expansion in Gulf

Equity, Debt, VC, Private E...

Financial Statements

Trading Restriction Update

Financial Statements

Financial Statements

Management Changes

Asset Acquisitions

Foreign Investment

Financial Results Publication

Regulatory Compliance

Increase in recognition

External Links:

Data:

VENUS REMEDIES LTD. has paid a total fine of Rs. 62,540 to BSE and will pay NSE's fine later due to an inadvertent error in reporting financial results for Q3 2023.

AI Assistant

Venus Remedies Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.